Yoga from home may speed lung cancer recovery
NCT ID NCT07001670
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an 8-week online yoga program can improve recovery in lung cancer patients who had lung surgery. Forty participants will either do live yoga sessions three times a week or receive standard care. The goal is to see if tele-yoga boosts exercise capacity, breathing, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tele-yoga (online yoga sessions)
- What this could lead to
- If it works, this could offer a convenient home-based option to help lung cancer patients recover faster after surgery.
- What could go wrong
- This is a small early-stage trial with only 40 participants, so results may not apply to everyone. The benefits of yoga for recovery are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Thoracic Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa
RECRUITINGIstanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Can a simple blood test predict leukemia risk after cancer therapy?